Daniel Karp
Director/Board Member bei CARTESIAN GROWTH CORPORATION II
Vermögen: 70 750 $ am 31.03.2024
Profil
Daniel Karp is an Independent Director at Cartesian Growth Corp.
II and the Chief Business Development Officer at Organon & Co. He previously served as an Independent Director at Cartesian Growth Corp., the VP-Worldwide Business Development at Pfizer Inc., and the Executive Vice President-Corporate Development at Biogen, Inc. Mr. Karp obtained his undergraduate degree from Duke University and his MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
20.01.2023 | 12 500 ( 0,02% ) | 70 750 $ | 31.03.2024 |
Aktive Positionen von Daniel Karp
Unternehmen | Position | Beginn |
---|---|---|
CARTESIAN GROWTH CORPORATION II | Director/Board Member | 23.12.2021 |
ORGANON & CO. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Daniel Karp
Unternehmen | Position | Ende |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | 01.05.2020 |
PFIZER, INC. | Corporate Officer/Principal | 01.06.2018 |
ALVARIUM TIEDEMANN A | Director/Board Member | - |
Ausbildung von Daniel Karp
Duke University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
PFIZER, INC. | Health Technology |
BIOGEN INC. | Health Technology |
ORGANON & CO. | Health Technology |
CARTESIAN GROWTH CORPORATION II | Finance |
Private Unternehmen | 1 |
---|---|
Cartesian Growth Corp.
Cartesian Growth Corp. Financial ConglomeratesFinance Cartesian Growth Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2020 and is headquartered in New York, NY. | Finance |